1. Home
  2. WMK vs ANIP Comparison

WMK vs ANIP Comparison

Compare WMK & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Weis Markets Inc.

WMK

Weis Markets Inc.

N/A

Current Price

$78.75

Market Cap

2.0B

ML Signal

N/A

Logo ANI Pharmaceuticals Inc.

ANIP

ANI Pharmaceuticals Inc.

N/A

Current Price

$71.41

Market Cap

1.9B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WMK
ANIP
Founded
1912
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Food Chains
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.9B
IPO Year
1994
1999

Fundamental Metrics

Financial Performance
Metric
WMK
ANIP
Price
$78.75
$71.41
Analyst Decision
Buy
Analyst Count
0
8
Target Price
N/A
★ $103.38
AVG Volume (30 Days)
142.3K
★ 371.8K
Earning Date
11-03-2026
11-05-2026
Dividend Yield
★ 1.73%
N/A
EPS Growth
N/A
★ 419.23
EPS
2.95
★ 3.86
Revenue
★ $4,714,573,000.00
$206,547,000.00
Revenue This Year
N/A
$24.30
Revenue Next Year
N/A
$10.96
P/E Ratio
$26.87
★ $18.45
Revenue Growth
0.01
★ 2.47
52 Week Low
$59.99
$67.38
52 Week High
$83.84
$87.76

Technical Indicators

Market Signals
Indicator
WMK
ANIP
Relative Strength Index (RSI) 54.51 48.65
Support Level $76.47 N/A
Resistance Level $81.50 $74.86
Average True Range (ATR) 2.54 2.48
MACD 0.16 0.06
Stochastic Oscillator 47.03 43.91

Price Performance

Historical Comparison
WMK
ANIP

About WMK Weis Markets Inc.

Weis Markets Inc is a U.S.-based company that is principally engaged in retailing food products in Pennsylvania and surrounding states. The company's products mainly belong to the following categories: center-store goods, fresh goods, pharmacy services, fuel, and others. The center-store goods include groceries, dairy products, frozen foods, alcoholic beverages, and general merchandise items. The fresh goods include meats, seafood, floral, prepared foods, and bakery products. The company operates in a single segment, which is the retail segment. It derives revenues from customers through the retail sale of products including grocery, pharmacy and fuel from company owned supermarkets. The company derives all its revenue from sales within Pennsylvania and surrounding states.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc is a diversified biopharmaceutical company. It is focused on developing, manufacturing, and commercializing therapeutics through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; and through its Generics and Brands businesses. The firm's product portfolio comprises Purified Cortrophin Gel, ILUVIEN, and YUTIQ (fluocinolone acetonide intravitreal implant), among others. Additionally, its Generics portfolio includes several products with a wide variety of indications. The company has two operating segments: Rare Disease and Brands, which derive maximum revenue, and Generics and Other. Geographically, it generates maximum revenue from the United States, followed by other markets.

Share on Social Networks: